Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Exelixis Stock Treads Water Ahead Of FDA Decision
Exelixis Stock Treads Water Ahead Of FDA Decision
Exelixis Stock Treads Water Ahead Of FDA Decision
Submitted by
admin
on October 27, 2012 - 11:30am
Source:
Seeking Alpha
News Tags:
cabozantinib
medullary thyroid cancer
thyroid cancer
Headline:
Exelixis Stock Treads Water Ahead Of FDA Decision
Do Not Allow Advertisers to Use My Personal information
